TrialPituitary2022

Paltusotine, a novel oral once-daily nonpeptide SST2 receptor agonist, suppresses GH and IGF-1 in healthy volunteers.

Ajay Madan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.